Renal angiotensin II receptors and protein kinase C in diabetic rats: Effects of insulin and ACE inhibition

American Journal of Physiology - Renal Physiology

Volumn 278, Issue 4 47-4, 2000, Pages

  Amiri, Farhad ^a,b   Garcia, Raul ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Angiotensin converting enzyme; Insulin; Receptors; Streptozotocin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN RECEPTOR; CAPTOPRIL; HUMAN INSULIN; HUMULIN U; ISOENZYME; LOSARTAN; PROTEIN KINASE C; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; STREPTOZOCIN DIABETES;

EID: 0034005283     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.278.4.f603     Document Type: Article

References (48)

1. Allen TJ, Cao Z, Youssef S, Hulthen UL, and Cooper ME. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies. Diabetes 46: 1612-1618, 1997.
2. Amiri F and Garcia R. Differential regulation of renal glomerular and preglomerular vascular angiotensin II receptors. Am J Physiol Endocrinol Metab 270: E810-E815, 1996.
3. Amiri F and Garcia R. Renal angiotensin II receptor regulation in two-kidney, one clip hypertensive rats. Effect of ACE inhibition. Hypertension 30: 337-344, 1997.
4. Amiri F and Garcia R. Regulation of angiotensin II receptors and PKC isoforms by glucose in rat mesangial cells. Am J Physiol Renal Physiol 276: F691-F699, 1999.
5. Anderson S, Meyer TW, Rennke HG, and Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619, 1985.
6. Arima S, Ito S, Omata K, Takeuchi K, and Abe K. High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles. Kidney Int 48: 683-689, 1995.
7. Awazu M, Parker RE, Harvie BR, Ichikawa I, and Kon V. Down-regulation of endothelin-1 receptors by protein kinase C in streptozotocin diabetic rats. J Cardiovasc Pharmacol 17, Suppl 7: S500-S502, 1991.
8. Babazono T, Kapor-Drezgic J, Dlugosz JA, and Whiteside C. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 47: 668-676, 1998.
9. Bottari SP, De Jasper M, Stockings UM, and Levens NR. Angiotensin II receptor subtypes. Characterization, signaling mechanism and possible physiological implications. Front Neuroendocrinol 14: 123-171, 1993.
10. Carney SL, Wong NLM, and Dirks JH. Acute effects of streptozotocin diabetes on rat renal function. J Lab Clin Med 93: 950-961, 1979.
11. Cheng H-F, Burns KD, and Harris RC. Reduced proximal tubule angiotensin II receptor expression in streptozotocin-induced diabetes mellitus. Kidney Int 46: 1603-1610, 1994.
12. 1 receptors are essentially identical. Biochem Biophys Res Commun 197: 440-449, 1993.
13. Chiu AT, Herblin WF, McCall DE, Ardeckly RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWM. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 165: 196-203, 1989.
14. Craven PA, Davidson CM, and DeRubertis FR. Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39: 667-674, 1990.
15. Craven PA and DeRubertis FR. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats: possible mediation by glucose. J Clin Invest 83: 1667-1675, 1989.
16. De Gasparo M and Levens NR. Pharmacology of angiotensin II receptors in the kidney. Kidney Int 46: 1486-1491, 1994.
17. De Leon H and Garcia R. Angiotensin II receptor subtypes in rat renal preglomerular vessels. Receptor 2: 253-260, 1992.
18. Eadington DW, Swainson CP, Frier BM, and Semple PF. Renal responses to angiotensin II infusion in early type 1 (insulin-dependent) diabetes. Diabetic Med 8: 524-531, 1991.
19. Freener EP and King GL. Vascular dysfunction in diabetes mellitus. Lancet 350, Suppl 1: 9-13, 1997.
20. Gauquelin G and Garcia R. Characterization of glomerular angiotensin II receptor subtypes. Receptor 2: 207-212, 1992.
21. Griendling KK, Delafontaine P, Rittenhouse SE, Gimbrone MAJ, and Alexander RW. Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II-stimulated cultured vascular smooth muscle cells. J Biol Chem 262: 14555-14562, 1987.
22. Griendling KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MAJ, and Alexander RW. Sustained diacylglycerol formation from inositol phospholipids in angiotensin H-stimulated vascular smooth muscle cells. J Biol Chem 261: 5901-5906, 1986.
23. Gutkowska J, Boucher R, and Genest J. Dosage radioimmunologique de l'activité rénine plasmatique. Union Méd Can 106: 446-450, 1977.
24. Healy DP, Ye M-Q, and Troyanovskaya M. Localization of angiotensin II type 1 receptor subtype mRNA in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 268: F220-F226, 1995.
25. Herr RR, Eble TE, Bergy ME, and Jahnke HK. Isolation and characterization of streptozotocin. Antibiotics Annu 7: 236-240, 1960.
26. Hill MA and Larkins RG. Altered microvascular reactivity in streptozotocin-induced diabetes in rats. Am J Physiol Heart Circ Physiol 257: H1438-H1445, 1989.
27. Inoguchi T, Battan R, Handler E, Sportsman JR, Health W, and King GL. Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89: 11059-11063, 1992.
28. Iwai N and Inagami T. Identification of two subtypes in the rat type 1 angiotensin II receptor. FEBS Lett 298: 257-260, 1992.
29. Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K, Kraemer FB, Hoffman AR, and Schambelan M. The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat. J Am Soc Nephrol 4: 1337-1345, 1993.
30. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, and Inagami T. Molecular cloning of a novel angiotensin II receptor isoform in phosphotyrosine phosphatase inhibition. J Biol Chem 268: 24543-24546, 1993.
31. Kikkawa R, Kitamura E, Fujiwara Y, Haneda M, and Shigeta Y. Diphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats. Renal Physiol 9: 187-192, 1986.
32. Liu F and Roth RA. Insulin-stimulated tyrosine phosphorylation of protein kinase Cα: evidence for direct interaction of the insulin receptor and protein kianse C in cells. Biochem Biophys Res Commun 200: 1570-1577, 1994.
33. Liu J-P. Protein kinase C and its substrates. Mol Cell Endocrinol 116: 1-29, 1996.
34. Maeda S, Kikkawa R, Haneda M, Togawa M, Koya D, Horide N, Kajiwara N, Uzu T, and Shigeta Y. Reduced activity of renal angiotensin-converting enzyme in streptozotocin-induced diabetic rats. J Diabetes Complications 5: 225-229, 1991.
35. Mogensen CE. Glomerular filtration rate and renal plasma flow in short-term and long-term diabetes mellitus. Scand J Clin Lab Invest 28: 91-100, 1971.
36. Morris AD, Boyle DIR, McMahon AD, Greene SA, MacDonald TM, and Newton RW. Adherence to insulin treatment, glycemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 350: 1505-1510, 1997.
37. Munson P and Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220-239, 1980.
38. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92: 10663-10667, 1995.
39. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661-665, 1988.
40. Pfeilschifter J. Protein kinase C from rat renal mesangial cells: its role in homologous desensitization of angiotensin II-induced polyphosphoinositide hydrolysis. Biochim Biophys Acta 969: 263-270, 1988.
41. Reineck HJ and Kreisberg JI. Renal vascular response to angiotensin II in rats with streptozotocin-induced diabetes mellitus (Abstract). Kidney Int 23: 247, 1983.
42. Spector T. Refinement of the Coomassie blue method of protein quantification. Anal Biochem 86: 142-146, 1978.
43. Tang EY, Parker PJ, Beattie J, and Houslay MD. Diabetes induces selective alterations in the expression of protein kinase C isoforms in hepatocytes. FEBS Lett 326: 117-123, 1993.
44. Timmermans PBMWM, Wong PC, Chiu AT, and Herblin WF. Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci 12: 55-62, 1991.
45. Wilkes BM. Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: Time course and mechanism. Endocrinology 120: 1291-1298, 1987.
46. Williams B, Tsai P, and Schrier RW. Glucose-induced downregulation of angiotensin II and arginine vasopressin receptors in cultured rat aortic vascular smooth muscle cells. Role of protein kinase C. J Clin Invest 90: 1992-1999, 1992.
47. Yamada T, Horiuchi M, and Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93: 156-160, 1996.
48. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, and Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986.